Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 18, 2010 |
| Target | Medical Consulting Dr. Schlichtiger |
| Sector | Life Science |
| Buyer(s) | Medpace |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Employees | 5,900 |
| Revenue | 2.1B USD (2024) |
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,700 people across 36 countries. Medpace was founded in 1992 and is based in Cincinnati, Ohio.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science | 1 of 2 |
| Type: Add-on Acquisition | 1 of 2 |
| Country: Germany | 1 of 1 |
| Year: 2010 | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-11-29 |
Symbios Clinical
Minneapolis, Minnesota, United States Symbios Clinical, Inc. is a provider of trial management, study design, protocol development, portfolio and data analysis,and process management services. |
Buy | - |
